|
|
| 06 May 2026 | 02:05 IST |
|
Aditya Birla SL Pharma & Healthcare Fund (G) |
|
|
|
|
|
|
|
| NAV Details |
| NAV Date : |
05-May-26 |
| NAV [Rs]: |
32.12 |
| Buy/Resale Price [Rs] : |
0.00 |
| Sell/Repurchase Price [Rs] : |
0.00 |
| Max Entry Load % : |
0.00 |
| Max Exit Load % : |
0.00 |
|
|
|
|
|
|
|
|
| Quantum of Dividend % |
NA |
NA |
| Date |
NA |
NA |
|
|
|
|
|
|
| Tax benefits : |
|
| Min. Investment(Rs.) : |
1000 |
| Increm.Investment(Rs.) : |
1000 |
|
|
|
|
|
| Statistical Ratios |
What
is Beta ?
Beta is a measure of the volatility of the portfolio to that of the index. In
simple words it shows the movement of the portfolio in comparison. The Higher
the Beta, higher the volatility of the scheme to the index. If its greater
than1 , then the portfolio is highly volatile to the movemnts in the index. If
the beta is lesser than 1 , then scheme is less volatile to the index and beta
which is close to 1 implies that the scheme is closely following the index.
|
| 0.7213 |
4.6275 |
0.9261 |
14.4743 |
0.0061 |
|
|
|
|
Sun Pharma.Inds.
|
13.42
|
|
Apollo Hospitals
|
7.34
|
|
Torrent Pharma.
|
5.03
|
|
J B Chemicals &
|
4.99
|
|
Aurobindo Pharma
|
4.42
|
|
Ajanta Pharma
|
4.22
|
|
Lupin
|
4.21
|
|
Ipca Labs.
|
4.11
|
|
Abbott India
|
3.90
|
|
Fortis Health.
|
3.49
|
|
Emcure Pharma
|
3.30
|
|
Cipla
|
3.24
|
|
Mankind Pharma
|
2.93
|
|
Shilpa Medicare
|
2.26
|
|
Alkem Lab
|
2.16
|
|
Corona Remedies
|
2.12
|
|
Sai Life
|
2.09
|
|
P & G Health Ltd
|
1.97
|
|
Jupiter Life Lin
|
1.96
|
|
Divi's Lab.
|
1.80
|
|
Sanofi Consumer
|
1.58
|
|
Dr Reddy's Labs
|
1.45
|
|
Thyrocare Tech.
|
1.44
|
|
Pfizer
|
1.40
|
|
Metropolis Healt
|
1.36
|
|
Alembic Pharma
|
1.24
|
|
Biocon
|
1.14
|
|
Jubilant Pharmo
|
1.11
|
|
Anthem Bioscienc
|
1.08
|
|
Gland Pharma
|
0.99
|
|
Piramal Pharma
|
0.92
|
|
Medi Assist Ser.
|
0.90
|
|
Suraksha Diagno.
|
0.89
|
|
Glaxosmi. Pharma
|
0.87
|
|
Vijaya Diagnost.
|
0.78
|
|
Max Healthcare
|
0.78
|
|
Vinati Organics
|
0.73
|
|
C C I
|
2.18
|
|
Net CA & Others
|
0.17
|
|
|
|
|
|
|
Asset Allocation
|
|
|
|
 |
|